Dianox CEO Mari Hedberg. Photo by EdelPhoto.

Delayed or inappropriate treatment of anaerobic infections may result in severe disease or death. With knowledge levels dropping in clinical laboratories, the need for anaerobic proficiency increase. Dianox is developing educational solutions to halt this trend in health care.

 A subset of bacteria that can have severe consequences

Anaerobic bacteria constitute a huge and heterogeneous group of microorganisms that are, more or less, susceptible to oxygen. Many species belong to the human normal micro-flora and are important for our well-being. Under certain conditions, like trauma, poor blood supply, surgery or malignancy, when anaerobic bacteria get the opportunity to spread to, and thrive at the “wrong” body sites, they may cause severe infections, requiring rapid diagnosis and treatment.

Mistakes in the sampling of specimens sent to clinical bacteriology laboratories can cause pre-analytical errors, resulting in defective diagnosis and delayed/wrong/no treatment of the patient. Delayed or inappropriate treatment may lead to increased morbidity and mortality. Resistance to antimicrobial substances among anaerobic bacteria is increasing.

A looming knowledge gap on anaerobes in clinical laboratories

A great part of active microbiologists with proficiency in anaerobes at clinical laboratories are reaching retiring age in the near future (in Sweden). The skills in anaerobic bacteriology among clinicians and microbiologists at clinical laboratories need to be well-kept-up and shifted over to younger colleagues. Little is done at the basic medical education programs to fill this soon coming gap of knowledge. The responsibility to secure that knowledge in anaerobic bacteriology is preserved, lays upon each lab. A need analysis, performed during 2017 in Sweden, verified that education in anaerobic bacteriology is wanted among the staff at clinical laboratories.

Dianox develops sought-after vocational training on anaerobes

To meet this medical and educational need, face-to-face and online courses for the different medical staff groups (nurses, clinicians and lab-personnel) will be developed. The courses will be settled in close contact with the target groups to enable that the courses get the special design required for each profession.

Over-booked face-to face courses in recent years have confirmed the crucial need of education on the topic. To meet this medical and educational need, online education programs will be developed for different medical staff groups (nurses, clinicians and lab-personnel). The courses will be settled in close contact with the target groups to enable that the programs get the special design required for each profession. The end-users of the education programs will be well up-dated to a reasonable cost.

The first online prototype course on anaerobic bacteriology by Dianox is planned to be initiated during spring 2019.

UBI Incubation Phase

Verify 1

Contact Information

Umeå Biotech Incubator
Tvistevägen 48C
907 36 Umeå
Mari Hedberg
Founder and CEO of Dianox AB, Biomedical Scientist (BMA), PhD, Associate Professor